Organic compounds
US9198924B2 · kind B2 · utility
22Cited by
29References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 13, 2007 |
| Grant date | Dec 1, 2015 |
| Priority date | — |
| Expiry date | May 18, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a new use of phosphodiesterase 1 (PDE1) inhibitors for the treatment and/or prophylaxis of narcolepsy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.